Brian M Bourgeois, MD | |
200 Lapalco Blvd Ste 1-b, Gretna, LA 70056-7113 | |
(504) 433-5070 | |
(504) 433-5077 |
Full Name | Brian M Bourgeois |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 200 Lapalco Blvd Ste 1-b, Gretna, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023191244 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 10467R (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brian M Bourgeois, MD 200 Lapalco Blvd Ste 1-b, Gretna, LA 70056-7113 Ph: (504) 433-5070 | Brian M Bourgeois, MD 200 Lapalco Blvd Ste 1-b, Gretna, LA 70056-7113 Ph: (504) 433-5070 |
News Archive
NPR's "All Things Considered" on Wednesday examined how Islam influences health and family planning decisions in Pakistan, one of Asia's fastest-growing populations.
As complaints and cavils about the Affordable Care Act fall by the wayside, one piece of the law looms ever larger as its most controversial element: the employer mandate, which in 2016 will impose a penalty on businesses with 50 to 99 employees for not offering them health coverage (Michael Hiltzik, 5/12).
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that new preclinical data of their investigational compound custirsen in castrate resistant prostate cancer were presented this week at the 102nd Annual Meeting of the AACR.
EntreMed, Inc., today announced receipt of a letter from the NASDAQ Stock Market stating that the Company has regained compliance with the $1.00 minimum closing bid price requirement and that, accordingly, it has determined to continue the listing of EntreMed's common stock on the NASDAQ Capital Market.
Atherosclerosis is the most common cause of cardiovascular disease, and results from chronic inflammation of arterial vessel walls. An international collaboration led by Professor Christian Weber of Ludwig-Maximilians-Universität (LMU) in Munich and Privatdozentin Alma Zernecke of Würzburg University now shows that dendritic cells stimulate this process by derailing a mechanism that normally acts as a brake on immune reactions.
› Verified 7 days ago